𝔖 Bobbio Scriptorium
✦   LIBER   ✦

6610 POSTER Safety of bevacizumab treatment in non-small cell lung cancer (NSCLC) subjects receiving full-dose anti-coagulation (FDAC) treated on protocol BO17704

✍ Scribed by Leighl, N.; Bennouna, J.; Kuo, H.; Szima, B.; Gottfried, M.; Kunitsyn, A.; Trigo, J.; Chang, G.; Cosaert, J.; Reck, M.


Book ID
123354854
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
60 KB
Volume
5
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES